AI Verdict
LLY has stronger fundamentals based on our AI analysis.
LLY vs VRTX Fundamental Comparison
| Metric | LLY | VRTX |
|---|---|---|
| Revenue | $19.8B | $3.0B |
| Net Income | $7.4B | $1.0B |
| Net Margin | 37.4% | 34.5% |
| ROE | 23.7% | 5.3% |
| ROA | 6.3% | 3.9% |
| Current Ratio | 1.50x | 3.02x |
| Debt/Equity | 1.26x | 0.01x |
| EPS | $8.26 | $4.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LLY vs VRTX: Frequently Asked Questions
Is LLY or VRTX the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LLY has stronger fundamentals. LLY is graded A (86% confidence) while VRTX is graded A (81% confidence). This is not investment advice.
How does LLY compare to VRTX fundamentally?
ELI LILLY & Co has ROE of 23.7% vs VERTEX PHARMACEUTICALS INC / MA's 5.3%. Net margins are 37.4% vs 34.5% respectively.
Which stock pays higher dividends, LLY or VRTX?
LLY has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LLY or VRTX for long term?
For long-term investing, consider that LLY has a A grade with 86% confidence, while VRTX has a A grade with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LLY vs VRTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LLY vs VRTX, the AI consensus favors LLY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.